This test is most useful if any of these apply to you.
If you get an itchy mouth, swollen lips, or worse after drinking soy milk or eating edamame, and you also struggle with spring tree-pollen allergies, this test can help explain why. Gly m 4 IgE measures the antibodies your immune system has made against a particular soy protein that closely resembles a protein in birch pollen, which is why people allergic to birch pollen sometimes react to soy.
A result here is not a verdict by itself. Many people carry these antibodies and eat soy without trouble, while others have severe reactions to soy drinks specifically. Your number is most useful when paired with your symptom history and, often, a few related allergy components.
Gly m 4 IgE (immunoglobulin E, the antibody class that drives allergic reactions) is a protein in your blood made by certain immune cells (IgE-producing memory B cells and plasmablasts). It specifically targets Gly m 4, a soy protein in the PR-10 family that looks structurally similar to Bet v 1, the main allergen in birch pollen.
Because the two proteins resemble each other, the antibodies your body makes against birch pollen can recognize Gly m 4 in soy. This is called cross-reactivity, and it is the foundation of birch-related soy allergy. In one study of birch-pollen-allergic adults with soy allergy, 96% (21 out of 22) had detectable Gly m 4 IgE in blood, and all of them also had birch-specific (Bet v 1) IgE.
Gly m 4 is recognized as the major soy allergen in adults whose soy reactions are tied to birch pollen allergy. Reactions can range from oral allergy syndrome (itching and swelling in the mouth and throat) to systemic symptoms, particularly after drinking soy milk. In adults, higher Gly m 4 IgE levels have been linked specifically to soy milk reactions, with a median level of 9.8 kU/L in soy-milk-reactive patients compared to 1.1 kU/L in those who reacted to other soy foods.
Birch pollen allergy is common across Europe, North America, and parts of Asia, and many people with this allergy never connect their springtime sneezing with a sudden bad reaction to a soy latte. Knowing your Gly m 4 number adds a piece of evidence that can explain confusing food reactions.
This is the single most important thing to understand about Gly m 4 IgE. Having the antibody (sensitization) does not mean you will react to soy. In a group of 94 birch-pollen-allergic patients, about 71% had Gly m 4 IgE in their blood, but only about 10% reported actual soy allergy symptoms.
An updated meta-analysis of allergy tests reports that Gly m 4 IgE has roughly 61% sensitivity and 69% specificity for true IgE-mediated soy allergy. In plain terms, it catches a majority of cases but misses some, and a positive result can also appear in people who tolerate soy without issue. That is why your symptom story matters as much as the number on the page.
A high Gly m 4 IgE result is not a reliable predictor of how severe your soy reactions will be. Antibody levels do not correlate with reaction severity in birch-related soy allergy. In one European cohort, detectable Gly m 4 IgE was actually linked to lower odds of severe soy reactions compared with milder ones (odds ratio 0.07).
Severe soy anaphylaxis is more strongly tied to a different family of soy proteins called storage proteins, particularly Gly m 5 and Gly m 6. If your main concern is identifying risk of a severe systemic reaction, Gly m 4 alone is not the right answer. That said, soy milk reactions in people sensitized to Gly m 4 can still be severe, especially in birch-pollen-allergic children. The level alone cannot tell you which way your body will go.
It might seem paradoxical that Gly m 4 IgE is the leading marker for birch-related soy allergy and yet does not predict severity or even guarantee a reaction. The resolution is that Gly m 4 IgE is a phenotype indicator, not a severity meter. It tells you which allergy pathway you are on (the birch-cross-reactive PR-10 pathway), not how loud the alarm will be when you eat soy. People on this pathway often experience oral symptoms, sometimes more, but the protein itself is partially degraded by digestion and heat, which is why reactions vary. Severity tracks better with the storage-protein components, not Gly m 4.
Soy allergy testing has improved considerably with component-resolved diagnostics, which break soy into its individual proteins instead of using a soy extract that mixes them all together. Each component answers a different question about your immune response.
| Soy Component | What It Tells You | Diagnostic Strength |
|---|---|---|
| Gly m 4 (PR-10 protein) | Birch-related sensitization, often oral or soy-milk reactions | Sensitivity around 61%, specificity around 69% for soy allergy |
| Gly m 2S albumin | Best overall component for soy allergy in adults and children | AUC around 0.79 in adults, 0.75 in children, where 1.0 would be perfect |
| Gly m 5 and Gly m 6 (storage proteins) | Risk of severe systemic soy reactions | Strongly associated with severe reactions, around 12 times the odds in one cohort |
Source: Riggioni et al. 2023 meta-analysis; Klemans et al. 2013; Ebisawa et al. 2013; Holzhauser et al. 2009. What this means for you: if you want a full read on your soy allergy risk, Gly m 4 is one piece of the puzzle. Ordering Gly m 2S albumin, Gly m 5, and Gly m 6 alongside it gives a much sharper picture of both whether you are truly allergic and how severely you might react.
Allergen-specific IgE results are most informative when you have more than one data point. A baseline number tells you whether you are sensitized to Gly m 4 right now. A repeat test a year or two later, especially alongside your symptom history, can show whether your sensitization is stable, growing, or fading. This matters because childhood IgE patterns to PR-10 proteins (the family Gly m 4 belongs to) can predict future birch-pollen allergic rhinitis, and adult patterns can shift with new exposures.
A reasonable approach: get a baseline if you suspect birch-related food reactions or want to map your allergy profile, retest in 6 to 12 months if your symptoms change, and otherwise check every one to two years as part of an allergy panel. Single readings are rarely the whole story, especially for a marker that does not move in lockstep with disease severity.
A positive Gly m 4 IgE in someone with no soy symptoms usually means birch-related sensitization without clinical allergy. The right next steps are not a soy ban but a fuller picture: order Gly m 2S albumin, Gly m 5, and Gly m 6 if you have not already, and check Bet v 1 (birch pollen) IgE to confirm the cross-reactivity. If you have had any reactions, an allergist can interpret the panel in the context of your symptom history and, if needed, arrange a supervised food challenge.
A negative or low Gly m 4 IgE makes birch-related soy allergy less likely, but it does not rule out soy allergy through other proteins. If you have had a clear reaction to soy and Gly m 4 is low, ask about the storage-protein components, because they cover a different mechanism. An allergist or immunologist becomes valuable when results and symptoms point in different directions, or when severe reactions are in your history.
Two patterns explain most confusion with this test. The first is high IgE in someone who tolerates soy: this is sensitization without clinical allergy, common in birch-pollen-allergic people. The second is a clear reaction with low IgE: this often points to allergy through a different soy protein, especially the storage proteins, which Gly m 4 alone will not detect. Heavy processing (heating, fermentation) lowers Gly m 4 content in soy foods, which is why some sensitized people tolerate cooked tofu but react to soy milk. Severe reactions in birch-pollen-allergic individuals are most consistently triggered by soy drinks specifically.
Soy (Gly m 4) IgE is best interpreted alongside these tests.